Marshall Wace, LLP Cardiovascular Systems Inc Transaction History

Marshall Wace, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $672,502 - $893,028	52,011 New	52,011 $720,000
Q2 2022 Aug 15, 2022	SELL	$13.53 - $23.34 $193,167 - $333,225	-14,277 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$16.14 - $22.6 $971,192 - $1.36 Million	-60,173 Reduced 80.82%	14,277 $323,000
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $1.24 Million - $2.44 Million	66,492 Added 835.54%	74,450 $1.4 Million
Q3 2021 Nov 15, 2021	SELL	$32.83 - $43.0 $54,071 - $70,821	-1,647 Reduced 17.15%	7,958 $261,000
Q1 2021 May 17, 2021	SELL	$37.29 - $47.19 $1.74 Million - $2.2 Million	-46,699 Reduced 82.94%	9,605 $368,000
Q4 2020 Feb 16, 2021	SELL	$34.3 - $44.09 $3.13 Million - $4.03 Million	-91,314 Reduced 61.86%	56,304 $2.46 Million
Q3 2020 Nov 16, 2020	BUY	$27.86 - $39.35 $303,283 - $428,364	10,886 Added 7.96%	147,618 $5.81 Million
Q2 2020 Aug 13, 2020	BUY	$30.3 - $42.55 $4.14 Million - $5.82 Million	136,732 New	136,732 $4.32 Million
Q4 2018 Feb 14, 2019	SELL	$25.26 - $38.43 $587,850 - $894,342	-23,272 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$33.27 - $39.25 $774,259 - $913,426	23,272 New	23,272 $911,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.